Advertisements

Esperion Therapeutics Inc. (ESPR) Stock Quote

Detailed Quote for Esperion Therapeutics Inc. (ESPR)
$ 35.66   -2.61 (-6.82%) Volume: 2.17m 4:00 PM EDT Mar 28, 2017
After Hours:  $ 36.40   0.74 (+2.08%) Volume: 10.6k 7:15 PM EDT Mar 28, 2017
Today 5d 1m 3m 1y more
Last Price
35.66
Change $
2.61
Change %
6.82%
Tick
  
Bid
36.05
Bid Size
300
Ask
36.40
Ask Size
100
Open
38.44
High
38.72
Low
35.395
Prev Close
38.27
Last Trade
4:00
Volume
2.17m
52 Wk Hi
48.209999
52 Wk Low
9.39999961
Market Cap
804.35m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
22,556,038
EPS (TTM)
-3.32999992
PE Ratio
N/A
Exchange
NSD
News and Media for Esperion Therapeutics Inc. (ESPR)
Sector News | Topic News
News for Esperion Therapeutics Inc. (ESPR)
Tue, Mar 28, 2017
4:30 PM Esperion to Participate in Fireside Chat at the 16th Annual Needham Healthcare Conference - GlobeNewswire
Fri, Mar 24, 2017
11:16 AM InsiderInsights.com Daily Round Up 3/23/17: IPI, RCII, AMH, FSC - SeekingAlpha
Tue, Mar 21, 2017
9:31 AM The Difference Between Spectacular News and No News - Accesswire
9:24 AM Premarket Gainers as of 9:10 am - SeekingAlpha
9:14 AM Esperion Therapeutics up another 7%; Citi doubles price target - SeekingAlpha
Mon, Mar 20, 2017
3:57 PM Esperion Therapeutics (ESPR) Presents At ACC 66th Annual Scientific Session (Genetic Validation of ACL) - Slideshow - SeekingAlpha
12:47 PM Midday Gainers / Losers - SeekingAlpha
9:23 AM FDA on board with Esperion's late-stage development program for bad cholesterol-lowering claim for bempedoic acid; shares ahead 33% premarket - SeekingAlpha
9:15 AM Premarket Gainers as of 9:05 am - SeekingAlpha
7:30 AM Esperion Announces FDA Confirmation Regarding Regulatory Pathway to Approval for an LDL-C Lowering Indication for Bempedoic Acid - GlobeNewswire
Fri, Mar 17, 2017
12:47 PM Midday Gainers / Losers - SeekingAlpha
12:10 PM Healthcare - Top 5 Gainers / Losers as of 12:10 PM - SeekingAlpha
9:37 AM Amgen -6%, MDCO -22%, ESPR -30% after Repatha data - SeekingAlpha
9:16 AM Premarket Losers as of 9:05 am - SeekingAlpha
Wed, Mar 15, 2017
9:34 PM Health Care Stocks Aided by 3.1% Gain by Esperion Therapeutics Inc. (ESPR) on March 15 - FP News
Fri, Mar 10, 2017
11:25 AM Esperion Therapeutics Inc. (ESPR) Gives Up 5.85% at Midday on March 9, Pressuring Health Care Stocks - FP News
11:24 AM Esperion Therapeutics Inc. (ESPR) Pressures Healthcare Sector with a Slide of 4.61% on March 9 - FP News
Wed, Mar 08, 2017
10:26 PM Health Care Firm Esperion Therapeutics Inc. (ESPR) Advances 7.53% at Midday on March 8 - FP News
10:21 PM Health Care Stocks Aided by 8.59% Gain by Esperion Therapeutics Inc. (ESPR) on March 8 - FP News
Tue, Mar 07, 2017
8:30 AM Esperion Announces Initiation of Phase 2 Triplet Oral Therapy Study of Bempedoic Acid/Ezetimibe/Atorvastatin - GlobeNewswire
More News for ESPR >>

Tags for Esperion Therapeutics Inc.

Research stocks or mutual funds related to Esperion Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to ESPR. The keywords below have been associated to ESPR by either user submission or electronic means.